Iqvia Holdings (IQV) Capital Expenditures (2012 - 2026)
Iqvia Holdings' (IQV) quarterly Capital Expenditures came in at $198.0 million in Q2 2026, up 31.13% year-over-year from $151.0 million in Q2 2025, and up 55.91% quarter-over-quarter from $127.0 million in Q1 2026.
Analysis
Iqvia Holdings (IQV) Capital Expenditures (2012 - 2026) Analysis & Trends
Iqvia Holdings has disclosed Capital Expenditures across 15 years of filings, most recently posting $198.0 million for Q2 2026.
- In Q2 2026, Capital Expenditures rose 31.13% year-over-year to $198.0 million; the TTM figure through Jun 2026 stood at $635.0 million (up 4.61% YoY), while the FY2025 annual figure was $603.0 million, changed 0.17% from the prior year.
- Capital Expenditures came in at $198.0 million for Q2 2026 at Iqvia Holdings, up from $127.0 million in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $198.0 million in Q2 2026 to a low of $127.0 million in Q1 2026.
- Average Capital Expenditures over 5 years is $158.5 million, with a median of $160.5 million recorded in 2022.
- Year-over-year, Capital Expenditures declined 11.59% in 2024 and surged 31.13% in 2026.
- Over 5 years, Capital Expenditures stood at $171.0 million in 2022, then climbed by 4.68% to $179.0 million in 2023, then decreased by 8.38% to $164.0 million in 2024, then climbed by 6.1% to $174.0 million in 2025, then gained by 13.79% to $198.0 million in 2026.
- Per Business Quant data, the three most recent Capital Expenditures figures were $198.0 million in Q2 2026, $127.0 million in Q1 2026, and $174.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 198.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 23.91 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | -42.42 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 31.11 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 9.00 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 2.62 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 125,000.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -55,941.69 |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 23,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 198.00 Mn |
| Mar 31, 2026 | 127.00 Mn |
| Dec 31, 2025 | 174.00 Mn |
| Sep 30, 2025 | 136.00 Mn |
| Jun 30, 2025 | 151.00 Mn |
| Mar 31, 2025 | 142.00 Mn |
| Dec 31, 2024 | 164.00 Mn |
| Sep 30, 2024 | 150.00 Mn |
| Jun 30, 2024 | 143.00 Mn |
| Mar 31, 2024 | 145.00 Mn |
| Dec 31, 2023 | 179.00 Mn |
| Sep 30, 2023 | 146.00 Mn |
| Jun 30, 2023 | 160.00 Mn |
| Mar 31, 2023 | 164.00 Mn |
| Dec 31, 2022 | 171.00 Mn |
| Sep 30, 2022 | 165.00 Mn |
| Jun 30, 2022 | 161.00 Mn |
| Mar 31, 2022 | 177.00 Mn |
| Dec 31, 2021 | 184.00 Mn |
| Sep 30, 2021 | 162.00 Mn |